Literature DB >> 2871645

Monoclonal antibody analysis of canine hemopoietic cells. Role of Ia-like and Thy-1 antigens in bone marrow engraftment.

M M Prendergast, K F Bradstock, A F Broomhead, W G Hughes, A Kabral, M C Berndt, K Tiver.   

Abstract

The expression of Ia-like (class II MHC) antigens on canine hemopoietic cells was investigated using a cytotoxic murine monoclonal antibody, WM-2, reactive with dog Ia-like antigens. Another monoclonal antibody, WMD-1, reactive with canine Thy-1 antigen, was used as a positive control. Depletion of Ia+ cells from dog bone marrow by complement-mediated lysis with WM-2 antibody failed to inhibit growth of granulocyte-macrophage progenitors (CFUGM) in vitro, while WMD-1 produced complete inhibition of CFUGM. Lethally irradiated dogs receiving bone marrow autografts depleted of Ia-positive cells ex vivo showed initial engraftment, followed by prolonged pancytopenia, and eventual complete recovery of marrow function in the majority of animals. In contrast, dogs receiving autografts treated with WMD-1 and complement all died of marrow failure. We interpret these results as indicating: (1) that Thy-1 antigen is present on hemopoietic stem cells essential for marrow engraftment; and (2) that the expression of Ia antigens on hemopoietic cells is heterogeneous and related to the level of stem cell maturation. While Ia appears to be present on a stem cell population at an earlier stage than CFUGM, as evidenced by the transient phase of graft failure seen in dogs receiving Ia-depleted marrow, the most primitive stem cell, responsible for long-term engraftment, is effectively Ia-negative.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871645     DOI: 10.1097/00007890-198605000-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.

Authors:  P Hersey; M MacDonald; S Schibeci; C Burns
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Effect of preoperative thoracic duct drainage on canine kidney transplantation.

Authors:  Y Funakoshi; G Carrieri; A Yagihashi; Y Iwaki; S Todo; T E Starzl
Journal:  J Invest Surg       Date:  1996 Sep-Oct       Impact factor: 2.533

3.  Immunological characterization of canine hematopoietic progenitor cells.

Authors:  J Hahn; H J Kolb; M Schumm; K Beisser; J Ellwart; P Rieber; J Maldacker; N Schwella; L K Lösslein; E Holler
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

4.  Functional characterization of canine lymphocyte subsets.

Authors:  C Hötzl; H J Kolb; E Holler; J Hahn; M Schumm; K Beisser; J Mysliwietz; P Rieber; W Mempel; W Wilmanns
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

5.  Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining.

Authors:  Marcela L Moreira; Elaine M S Dorneles; Rodrigo P Soares; Camila P Magalhães; Christiane Costa-Pereira; Andrey P Lage; Andréa Teixeira-Carvalho; Olindo A Martins-Filho; Márcio S S Araújo
Journal:  Acta Vet Scand       Date:  2015-09-11       Impact factor: 1.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.